Wong, J., Malki, M. M. A., Yang, D., Adhikarla, V., Sahebi, F., Salhotra, A., Dandapani, S., Song, J., Han, C., Liu, A., Yamauchi, D., Ali, H., Koller, P., Amanam, I., Yazaki, P., Shively, J., Wu, A., Hui, S., Smith, E., Marcucci, G., Forman, S., Nakamura, R., Stein, A. S. (2025). First-in-human phase I trial combining radiopharmaceutical therapy (RPT) using a 90y-anti-CD25 monoclonal antibody (Mab) with total marrow and lymphoid irradiation (TMLI) in relapsed or refractory (R/R) acute leukemia. Blood. https://doi.org/10.1182/blood-2025-508